REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 74 filers reported holding REPROS THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $20,000 | -80.6% | 20,254 | -76.1% | 0.00% | – |
| Q4 2015 | $103,000 | -85.9% | 84,837 | -13.5% | 0.00% | -100.0% |
| Q3 2015 | $728,000 | -3.6% | 98,026 | -7.0% | 0.00% | 0.0% |
| Q2 2015 | $755,000 | -14.9% | 105,453 | +2.1% | 0.00% | 0.0% |
| Q1 2015 | $887,000 | +10.6% | 103,327 | +28.6% | 0.00% | 0.0% |
| Q4 2014 | $802,000 | +289.3% | 80,353 | +572.2% | 0.00% | +100.0% |
| Q2 2014 | $206,000 | -11.6% | 11,953 | -8.7% | 0.00% | 0.0% |
| Q1 2014 | $233,000 | +16.5% | 13,094 | +19.9% | 0.00% | 0.0% |
| Q4 2013 | $200,000 | -22.5% | 10,924 | +13.4% | 0.00% | 0.0% |
| Q3 2013 | $258,000 | – | 9,634 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $11,290,000 | 4.00% |
| SENZAR ASSET MANAGEMENT, LLC | 764,406 | $7,621,000 | 2.23% |
| DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $3,280,000 | 0.88% |
| RTW INVESTMENTS, LP | 229,364 | $2,287,000 | 0.85% |
| CQS Cayman LP | 700,000 | $6,979,000 | 0.46% |
| GENERAL AMERICAN INVESTORS CO INC | 508,375 | $5,068,000 | 0.40% |
| Alden Global Capital Ltd | 154,000 | $1,535,000 | 0.37% |
| J. Goldman & Co LP | 197,500 | $1,969,000 | 0.23% |
| Baker Brothers Advisors | 2,000,000 | $19,940,000 | 0.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 100,000 | $997,000 | 0.17% |